recall
saveAlembic Pharmaceuticals Limited recall (Cls III)
November 26, 2025updated 5mo ago
community read0 votes
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30 — Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. — Status: Ongoing
view source ↗Data sources
last refreshed 51m ago
Found something off?
same company · ±60 days · 6
- approvalropinirole hydrochloride ER: ROPINIROLE HYDROCHLORIDE — FDA approvalNov 19, 2025
- approvalDILTIAZEM HYDROCHLORIDE: DILTIAZEM HYDROCHLORIDE — FDA approvalNov 14, 2025
- approvalloteprednol etabonate: LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE) — FDA approvalDec 10, 2025
- approvaldexlansoprazole DR: DEXLANSOPRAZOLE — FDA approvalNov 12, 2025
- approvalSUMATRIPTAN SUCCINATE: SUMATRIPTAN SUCCINATE — FDA approvalNov 6, 2025
- approvalBUPROPION HYDROCHLORIDE: BUPROPION HYDROCHLORIDE — FDA approvalNov 6, 2025
🐶 often sniffed alongside
top 8- tagRecall15 co-mentions · 5 sources
- drugElyxyb6 co-mentions · 1 sources
- drugCELECOXIB6 co-mentions · 1 sources
- drugcelecoxib SR6 co-mentions · 1 sources
- drugCelebrex6 co-mentions · 1 sources
- drugfesoterodine fumarate ER6 co-mentions · 2 sources
- drugtadalafil3 co-mentions · 1 sources
- drugdoxepin hydrochloride3 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that